https://www.selleckchem.com/pr....oducts/cordycepin.ht
This review summarizes relevant aspects that have an impact on the predictive value of in-vitro AST and points out factors, potentially leading to an ineffective outcome of antibacterial treatment in veterinary practice. Knowing the reasons of inadequate beneficial effects can help to understand possible discrepancies between in-vitro susceptibility and in vivo efficacy and aid in undertaking strategies for an avoidance of treatment failures.Actinobacillus pleuropneumoniae is a Gram-negative pathogen that causes porcine pleuropneumon
Like
Comment
Share
